Flunarizine PCD Pharma Franchise Company
Cafoli Lifecare offers a Flunarizine PCD pharma franchise built on 6 tablet formulations manufactured at WHO-GMP certified facilities. This gives franchise partners a dependable neurology line for migraine and vertigo management.
What is Flunarizine?
Flunarizine is a selective calcium-channel blocker with additional antihistaminic activity. By reducing calcium overload in neurons and vascular smooth muscle it stabilises cerebral blood flow, which underlies its role in migraine prevention and the control of vertigo. Read its profile on PubChem.
Therapeutic Applications
Flunarizine is prescribed for the prophylaxis of migraine, and for the symptomatic treatment of vertigo of central and peripheral origin and vestibular disorders. It is used as a preventive, taken regularly rather than during an acute attack. Prescriptions come mainly from neurologists, ENT specialists and general physicians.
Why Flunarizine is a High-Potential Molecule for Distributors
Migraine and vertigo are common, chronic and recurrent, and flunarizine is a first-line preventive taken continuously for months — which translates into steady, predictable repeat prescriptions. Because it serves both neurology and ENT, the prescriber base is wide, and rising recognition of migraine as a treatable disorder is expanding the market. That makes it a reliable maintenance-therapy molecule for distributors.
Why Choose Cafoli Lifecare
Cafoli Lifecare provides territory-wise monopoly rights, WHO-GMP certified manufacturing, DCGI-approved formulations, complete promotional inputs and the backing of 1000+ franchise partners across India.
References
- PubChem: Flunarizine
- PubMed: Flunarizine literature
Our formulations of Flunarizine find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: